Concepedia

Christopher G. Duncan

CG

Statistics

Publications

19

Citations

1.9K

H-Index

16

Active since

2004

Affiliations

Duke Medical Center(Current)

Pediatric Brain Tumor Foundation

Duke University Hospital

Duke University

National Institute of Environmental Health Sciences

Christopher G. Duncan is an author at Duke Medical Center specializing in molecular oncology, genetics, and life sciences.

ORCID

Publications per year

2004–2023

19

Publications

19

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation

Peppi Koivunen, Sung-Woo Lee, Christopher G. Duncan et al. · Nature · 2012 · 722 citations · Full text

, , +2

A heterozygous <i>IDH1<sup>R132H/WT</sup></i> mutation induces genome-wide alterations in DNA methylation

Christopher G. Duncan, Benjamin G. Barwick, Genglin Jin et al. · Genome Research · 2012 · 182 citations · Full text

, , +17

OTX2 Is Critical for the Maintenance and Progression of Shh-Independent Medulloblastomas

David Cory Adamson, Qun Shi, Matthew Wortham et al. · Cancer Research · 2009 · 125 citations · Full text

, , +17

Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas

Genglin Jin, Zachary J. Reitman, Christopher G. Duncan et al. · Cancer Research · 2012 · 123 citations

, , +17

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

Christopher G. Duncan, Patrick Killela, Cathy A. Payne et al. · Oncotarget · 2010 · 121 citations · Full text

, , +17

1–5 of 19